Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
for Clear Cell Renal Cell Carcinoma
Drug: Cemiplimab
1 location in Oklahoma City
Sponsor: University of Oklahoma
Sex: All·Age: 18+
Code: NCT07223541·Phase 2·Recruiting